What stocks does Nippon India Nifty Pharma ETF hold?

Nippon India Nifty Pharma ETF holds a portfolio of Indian equity stocks disclosed monthly by Nippon India Mutual Fund to AMFI. The complete current holdings with weights and month-over-month changes are available on this page. Data is sourced from official AMFI portfolio disclosures.

Which AMC manages Nippon India Nifty Pharma ETF?

Nippon India Nifty Pharma ETF is managed by Nippon India Mutual Fund, a SEBI-registered Asset Management Company in India.

What category is Nippon India Nifty Pharma ETF?

Nippon India Nifty Pharma ETF is classified as a Index/ETF mutual fund under SEBI's mutual fund categorisation framework.

How often is Nippon India Nifty Pharma ETF portfolio data updated?

Portfolio holdings for Nippon India Nifty Pharma ETF are updated monthly. SEBI mandates all AMCs to disclose their complete portfolio within 10 days of each month end. RightAdvise sources this data directly from official AMFI portfolio disclosures.

← Nippon India Mutual Fund

Nippon India Nifty Pharma ETF

Index/ETF Data as of Aug 2026 Comparing Jul 2026 → Aug 2026

Share: WhatsApp X

⌕

Stocks Held

Aug 2026

Equity Holdings

₹1,759.47 Cr

Equity only, excl. debt & cash

Top 5 Weight

55.2%

High concentration

Top 10 Weight

78.8%

High concentration

Changes

0 new · 0 exits

Top Sector

Pharmaceuticals & Biotechnology

100.0% of portfolio

Launch Date

21 Jun 2021

5 years old

📋 What Happened This Month Among existing holdings, Divi's Laboratories Limited saw the biggest increase — now at 11.88% of the portfolio. Lupin Limited was trimmed the most, now at 5.25%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 100.0%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

How Has the NAV Performed?

1 year history · Nippon India Nifty Pharma ETF

-0.59%

+8.04%

+16.45%

+18.04%

Latest NAV

₹26.93

15 Sep 2026

52W High

₹27.96

-4% from High

52W Low

₹20.39

+32% from Low

Calendar Year Returns

Jan 1 to Dec 31 each year. Simple point-to-point — not CAGR.

2025

-2.5%

2024

+39.6%

2023

+34.4%

2022

-10.9%

Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg

16.9%

+ve in 72% windows

64.3% / -14.4%

3Y Rolling Avg

20.5% p.a.

+ve in 100% windows

26.9% / 13.9%

5Y Rolling Avg

13.7% p.a.

+ve in 100% windows

14.5% / 13.1%

Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff

-16.6%

Rec: May 2026 (1yr 9mo)

COVID-19 Crash

Pre-inception

Rec: N/A

2022 Rate Hike

-14.7%

Rec: Jun 2023 (1yr 6mo)

2018 IL&FS

Pre-inception

Rec: N/A

Risk Ratios

3 years daily NAV · Risk-free rate 6.5% p.a. · CAGR, Sharpe Ratio & Standard Deviation — Mutual Fund Guide →

Sharpe Ratio (3Y)

0.95

Return per unit of risk. >1 is good.

Sortino Ratio (3Y)

1.40

Penalises downside volatility only.

Std Deviation (3Y)

15.0%

Lower = more consistent returns.

NAV Chart ₹26.93 15 Sep 2026

Simple Moving Avg: Click to draw · click again to remove

Nippon India Nifty Pharma ETF

Chart shows indexed performance (base = 100). Actual NAV: ₹26.93

Sector Shift Industry allocation month-over-month

Jun 2026 → Jul 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	99.9%	99.8%	▼ -0.1%

Jul 2026 → Aug 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	99.8%	100.0%	▲ +0.2%

↑

Biggest Add

Divi's Laboratories Limited

+1.54% · now 11.88%

↓

Biggest Trim

Lupin Limited

-0.68% · now 5.25%

What Changed in the Portfolio This Month?

Comparing Jul 2026 → Aug 2026

Jul 2026 → Aug 2026

↑ 10 Increased ↓ 10 Decreased

#	Stock	Sector	Jul 2026	Aug 2026	Change
1	Divi's Laboratories Limited ₹209.16 Cr	Pharmaceuticals & Biotechnology	10.34%	11.88%	+1.54%
2	Glenmark Pharmaceuticals Limited ₹64.91 Cr	Pharmaceuticals & Biotechnology	3.40%	3.69%	+0.29%
3	Aurobindo Pharma Limited ₹82.62 Cr	Pharmaceuticals & Biotechnology	4.42%	4.69%	+0.27%
4	IPCA Laboratories Limited ₹47.69 Cr	Pharmaceuticals & Biotechnology	2.45%	2.71%	+0.26%
5	Gland Pharma Limited ₹39.98 Cr	Pharmaceuticals & Biotechnology	2.02%	2.27%	+0.25%
6	Laurus Labs Limited ₹129.53 Cr	Pharmaceuticals & Biotechnology	7.14%	7.36%	+0.22%
7	Sai Life Sciences Limited ₹35.01 Cr	Pharmaceuticals & Biotechnology	1.83%	1.99%	+0.16%
8	Piramal Pharma Limited ₹23.18 Cr	Pharmaceuticals & Biotechnology	1.23%	1.32%	+0.09%
9	Ajanta Pharma Limited ₹26.38 Cr	Pharmaceuticals & Biotechnology	1.47%	1.50%	+0.03%
10	Zydus Lifesciences Limited ₹50.51 Cr	Pharmaceuticals & Biotechnology	2.85%	2.87%	+0.02%

#	Stock	Sector	Jul 2026	Aug 2026	Change
1	Lupin Limited ₹92.39 Cr	Pharmaceuticals & Biotechnology	5.93%	5.25%	-0.68%
2	Sun Pharmaceutical Industries Limited ₹365.36 Cr	Pharmaceuticals & Biotechnology	21.29%	20.75%	-0.54%
3	Cipla Limited ₹137.85 Cr	Pharmaceuticals & Biotechnology	8.37%	7.83%	-0.54%
4	Alkem Laboratories Limited ₹54.22 Cr	Pharmaceuticals & Biotechnology	3.40%	3.08%	-0.32%
5	Torrent Pharmaceuticals Limited ₹129.18 Cr	Pharmaceuticals & Biotechnology	7.59%	7.34%	-0.25%
6	Biocon Limited ₹51.10 Cr	Pharmaceuticals & Biotechnology	3.07%	2.90%	-0.17%
7	Abbott India Limited ₹23.41 Cr	Pharmaceuticals & Biotechnology	1.46%	1.33%	-0.13%
8	Dr. Reddy's Laboratories Limited ₹122.33 Cr	Pharmaceuticals & Biotechnology	7.07%	6.95%	-0.12%
9	Mankind Pharma Limited ₹47.61 Cr	Pharmaceuticals & Biotechnology	2.82%	2.70%	-0.12%
10	Wockhardt Limited ₹27.04 Cr	Pharmaceuticals & Biotechnology	1.63%	1.54%	-0.09%

What Stocks Does This Fund Hold?

20 stocks — Aug 2026

#	Stock	Sector	Weight & Value
1	Sun Pharmaceutical Industries Limited ₹365.36 Cr	Pharmaceuticals & Biotechnology	20.75%
2	Divi's Laboratories Limited ₹209.16 Cr	Pharmaceuticals & Biotechnology	11.88%
3	Cipla Limited ₹137.85 Cr	Pharmaceuticals & Biotechnology	7.83%
4	Laurus Labs Limited ₹129.53 Cr	Pharmaceuticals & Biotechnology	7.36%
5	Torrent Pharmaceuticals Limited ₹129.18 Cr	Pharmaceuticals & Biotechnology	7.34%
6	Dr. Reddy's Laboratories Limited ₹122.33 Cr	Pharmaceuticals & Biotechnology	6.95%
7	Lupin Limited ₹92.39 Cr	Pharmaceuticals & Biotechnology	5.25%
8	Aurobindo Pharma Limited ₹82.62 Cr	Pharmaceuticals & Biotechnology	4.69%
9	Glenmark Pharmaceuticals Limited ₹64.91 Cr	Pharmaceuticals & Biotechnology	3.69%
10	Alkem Laboratories Limited ₹54.22 Cr	Pharmaceuticals & Biotechnology	3.08%
11	Biocon Limited ₹51.10 Cr	Pharmaceuticals & Biotechnology	2.90%
12	Zydus Lifesciences Limited ₹50.51 Cr	Pharmaceuticals & Biotechnology	2.87%
13	IPCA Laboratories Limited ₹47.69 Cr	Pharmaceuticals & Biotechnology	2.71%
14	Mankind Pharma Limited ₹47.61 Cr	Pharmaceuticals & Biotechnology	2.70%
15	Gland Pharma Limited ₹39.98 Cr	Pharmaceuticals & Biotechnology	2.27%
16	Sai Life Sciences Limited ₹35.01 Cr	Pharmaceuticals & Biotechnology	1.99%
17	Wockhardt Limited ₹27.04 Cr	Pharmaceuticals & Biotechnology	1.54%
18	Ajanta Pharma Limited ₹26.38 Cr	Pharmaceuticals & Biotechnology	1.50%
19	Abbott India Limited ₹23.41 Cr	Pharmaceuticals & Biotechnology	1.33%
20	Piramal Pharma Limited ₹23.18 Cr	Pharmaceuticals & Biotechnology	1.32%